Stock Earnings
A Guide To The Risks Of Investing In BriaCell Therapeutics Corp (BCTX)
BriaCell Therapeutics Corp’s recent filing unveils that its Director Lustig Marc acquired Company’s shares for reported $2.0 million on May
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.